Zurueck zur Suche

Reporte zur Charge U6824AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 2 IN 2 OH 1 NY 1

VAERS 2357704

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U6824AA

schwer
Staat
TX
Alter
11,0
Geschlecht
F
Eingang
05.07.2022
Impfdatum
24.06.2022
Beginn
24.06.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood test normal Cold sweat Dizziness Laboratory test normal Loss of consciousness Pallor

Symptomtext

Pt felt faint after receiving the vaccines, c/o blacking out & pain behind ears. Pt very pale & skin clammy. Laid down on floor with feet elevated. Pt alert, mom & brother with pt. B/P checked & pulse. B/P on the low side. Pulse strong, steady. 5-10 min. pt says feeling better, sat back on chair, skin dry, color to face. Allowed to go w/ family to area where pts being watched for 15 - 30 min. after vaccines. 10 min later, pt states she is backing out again & begins to faint. In private area laid down with feet elevated. Mom wants to call ambulance. 911 called, one of our team, paramedic, spoke with operator. Paramedics came, assessed pt and took to ER

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Mom called later that afternoon who said tests being done and bloodwork drawn. Mom called again Monday morning (this occurred on a Friday) Mom said all tests were negative & pt feeling fine. Had been dismissed from hospital Friday evening.
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
NKA
Vorherige Impfungen
-

VAERS 2308556

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge u6824aa

moderat
Staat
TX
Alter
17,0
Geschlecht
F
Eingang
03.06.2022
Impfdatum
01.06.2022
Beginn
01.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Fatigue Headache Malaise Mobility decreased Pain

Symptomtext

Feels sick , can't get out of bed, chills, fatigue, whole body hurts , has a headache after receiving her vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 1678977

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U6824AA

mild
Staat
OH
Alter
17,0
Geschlecht
F
Eingang
07.09.2021
Impfdatum
02.09.2021
Beginn
03.09.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Rash pruritic

Symptomtext

Next day had hive-like rash over both legs from the hips down. Some affected areas with itching. Topical Benadryl,. oral Benadryl followed by appointment with NP 9/7/21. Prescribed oral prednisone on this date. No improvement noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
Poison ivy
Vorgeschichte
N/A
Andere Medikamente
Prednisone 30 mg x 3 days; Prednisone 20 mg. x 3 days then Prednisone 10 mg. x 3 days. For poison ivy.
Allergien
Sulfa; Keflex
Vorherige Impfungen
-

VAERS 2652919

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6824AA

gering
Staat
NY
Alter
18,0
Geschlecht
F
Eingang
05.07.2023
Impfdatum
27.06.2023
Beginn
27.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient was given an expired MENACTRA injection with no reported adverse event; Initial information received on 03-Jul-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 18 years old female patient and it was reported patient was given an expired meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra] injection with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 27-JUN-2023, patient was given 0.5 mL of expired meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra] Solution for injection (batch/lot number: U6824AA; expiry date: 01-jun-2023; strength: standard; frequency: once; 1X) via intramuscular route in the left deltoid for immunization with no reported adverse event (expired product administered) (latency: same day). Action taken: Not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2128689

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U6824AA

gering
Staat
IN
Alter
0,8
Geschlecht
M
Eingang
21.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

two patients received MENQUADFI after the temperature excursion occurred; Initial information received on 08-Feb-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 10 years old male patient who experienced two patients received menquadfi after the temperature excursion occurred while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, TETANUS VACCINE TOXOID (ADACEL). On 02-Feb-2022, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE with the dose of 0.5ml with lot U6824AA via intramuscular route in unknown administration site. On 02-FEB-2022 the patient received menquadfi after the temperature excursion occurred (product temperature excursion issue) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (two patients received MENQUADFI after the temperature excursion occurred). At time of reporting, the outcome was Unknown for the event two patients received menquadfi after the temperature excursion occurred.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
ADACEL
Allergien
-
Vorherige Impfungen
-

VAERS 2128200

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U6824AA

gering
Staat
IN
Alter
-
Geschlecht
M
Eingang
19.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product temperature excursion issue

Symptomtext

temperature excursion with no reported adverse event; Patient received MENQUADFI after the temperature excursion occurred with no reported adverse event; Initial information received on 08-Feb-2022 regarding an unsolicited valid non-serious case was received from an other health professional. This case involves a 10 year old male patient who received meningococcal a-c-y-w135 (t conj) vaccine (Menquadfi) after the temperature excursion occurred with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular 5-component, tetanus vaccine toxoid (Adacel) as prophylactic vaccination. On 02-Feb-2022, the patient received a dose of suspect meningococcal a-c-y-w135 (t conj) vaccine at 0.5 ml, once (lot U6824AA, expiry date: unknown) via intramuscular route in the left arm as prophylactic vaccination. It was reported that on 02-Feb-2022 the patient received meningococcal a-c-y-w135 (t conj) vaccine after the temperature excursion occurred (Product temperature excursion issue) with no reported adverse event (poor quality product administered, latency: same day). Action taken with meningococcal vaccine was not applicable. It was not reported if the patient received a corrective treatment for the events (Patient received MENQUADFI after the temperature excursion occurred with no reported adverse event, temperature excursion with no reported adverse event). At time of reporting, the outcome was Unknown for the event patient received menquadfi after the temperature excursion occurred with no reported adverse event and was Unknown for the event temperature excursion with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product temperature excursion issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
ADACEL
Allergien
-
Vorherige Impfungen
-